Cargando…

Gestational diabetes mellitus in the COVID‐19 pandemic: A retrospective study from Hangzhou, China

AIMS: Our study aimed to investigate changes in the prevalence of gestational diabetes mellitus (GDM) in the COVID‐19 pandemic and postpandemic era and the risk of adverse pregnancy outcomes in pregnant women diagnosed with GDM during the blockade period. METHODS: First, we investigated changes in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Binbin, Wu, Kaiqi, Hu, Lingwei, Zheng, Wanlu, Zheng, Yidan, Duan, Xiuzhi, Zhu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574731/
https://www.ncbi.nlm.nih.gov/pubmed/36181374
http://dx.doi.org/10.1111/1753-0407.13324
_version_ 1784811166126571520
author Yin, Binbin
Wu, Kaiqi
Hu, Lingwei
Zheng, Wanlu
Zheng, Yidan
Duan, Xiuzhi
Zhu, Bo
author_facet Yin, Binbin
Wu, Kaiqi
Hu, Lingwei
Zheng, Wanlu
Zheng, Yidan
Duan, Xiuzhi
Zhu, Bo
author_sort Yin, Binbin
collection PubMed
description AIMS: Our study aimed to investigate changes in the prevalence of gestational diabetes mellitus (GDM) in the COVID‐19 pandemic and postpandemic era and the risk of adverse pregnancy outcomes in pregnant women diagnosed with GDM during the blockade period. METHODS: First, we investigated changes in the prevalence of GDM and the population undergoing oral glucose tolerance tests (OGTT) after the COVID‐19 pandemic. We then collected clinical information from pregnant women diagnosed with GDM to explore the risk of adverse pregnancy outcomes in pregnant women with GDM during the COVID‐19 pandemic. RESULTS: After the COVID‐19 pandemic, the proportion of pregnant women in the total number of outpatient OGTT tests decreased yearly. The ratio was 81.30%, 79.71%, and 75.48% from 2019 to 2021, respectively, with the highest proportion of pregnant women in February 2020 (92.03%). The prevalence of GDM was higher in March 2020 compared to the same period in 2019. However, from 2019 to 2021, the prevalence decreased year by year with 21.46%, 19.81%, and 18.48%, respectively. The risk of adverse pregnancy outcomes for pregnant women diagnosed with GDM during the most severe period of the COVID‐19 pandemic did not differ from before the COVID‐19 pandemic. CONCLUSIONS: After the COVID‐19 pandemic, the prevalence of GDM increased during the most severe period of the epidemic, but the overall prevalence of GDM decreased year by year. In addition, the pandemic did not change the risk of adverse pregnancy outcomes in pregnant women with GDM.
format Online
Article
Text
id pubmed-9574731
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wiley Publishing Asia Pty Ltd
record_format MEDLINE/PubMed
spelling pubmed-95747312022-10-17 Gestational diabetes mellitus in the COVID‐19 pandemic: A retrospective study from Hangzhou, China Yin, Binbin Wu, Kaiqi Hu, Lingwei Zheng, Wanlu Zheng, Yidan Duan, Xiuzhi Zhu, Bo J Diabetes Original Articles AIMS: Our study aimed to investigate changes in the prevalence of gestational diabetes mellitus (GDM) in the COVID‐19 pandemic and postpandemic era and the risk of adverse pregnancy outcomes in pregnant women diagnosed with GDM during the blockade period. METHODS: First, we investigated changes in the prevalence of GDM and the population undergoing oral glucose tolerance tests (OGTT) after the COVID‐19 pandemic. We then collected clinical information from pregnant women diagnosed with GDM to explore the risk of adverse pregnancy outcomes in pregnant women with GDM during the COVID‐19 pandemic. RESULTS: After the COVID‐19 pandemic, the proportion of pregnant women in the total number of outpatient OGTT tests decreased yearly. The ratio was 81.30%, 79.71%, and 75.48% from 2019 to 2021, respectively, with the highest proportion of pregnant women in February 2020 (92.03%). The prevalence of GDM was higher in March 2020 compared to the same period in 2019. However, from 2019 to 2021, the prevalence decreased year by year with 21.46%, 19.81%, and 18.48%, respectively. The risk of adverse pregnancy outcomes for pregnant women diagnosed with GDM during the most severe period of the COVID‐19 pandemic did not differ from before the COVID‐19 pandemic. CONCLUSIONS: After the COVID‐19 pandemic, the prevalence of GDM increased during the most severe period of the epidemic, but the overall prevalence of GDM decreased year by year. In addition, the pandemic did not change the risk of adverse pregnancy outcomes in pregnant women with GDM. Wiley Publishing Asia Pty Ltd 2022-10-01 /pmc/articles/PMC9574731/ /pubmed/36181374 http://dx.doi.org/10.1111/1753-0407.13324 Text en © 2022 The Authors. Journal of Diabetes published by Ruijin Hospital, Shanghai JiaoTong University School of Medicine and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Yin, Binbin
Wu, Kaiqi
Hu, Lingwei
Zheng, Wanlu
Zheng, Yidan
Duan, Xiuzhi
Zhu, Bo
Gestational diabetes mellitus in the COVID‐19 pandemic: A retrospective study from Hangzhou, China
title Gestational diabetes mellitus in the COVID‐19 pandemic: A retrospective study from Hangzhou, China
title_full Gestational diabetes mellitus in the COVID‐19 pandemic: A retrospective study from Hangzhou, China
title_fullStr Gestational diabetes mellitus in the COVID‐19 pandemic: A retrospective study from Hangzhou, China
title_full_unstemmed Gestational diabetes mellitus in the COVID‐19 pandemic: A retrospective study from Hangzhou, China
title_short Gestational diabetes mellitus in the COVID‐19 pandemic: A retrospective study from Hangzhou, China
title_sort gestational diabetes mellitus in the covid‐19 pandemic: a retrospective study from hangzhou, china
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574731/
https://www.ncbi.nlm.nih.gov/pubmed/36181374
http://dx.doi.org/10.1111/1753-0407.13324
work_keys_str_mv AT yinbinbin gestationaldiabetesmellitusinthecovid19pandemicaretrospectivestudyfromhangzhouchina
AT wukaiqi gestationaldiabetesmellitusinthecovid19pandemicaretrospectivestudyfromhangzhouchina
AT hulingwei gestationaldiabetesmellitusinthecovid19pandemicaretrospectivestudyfromhangzhouchina
AT zhengwanlu gestationaldiabetesmellitusinthecovid19pandemicaretrospectivestudyfromhangzhouchina
AT zhengyidan gestationaldiabetesmellitusinthecovid19pandemicaretrospectivestudyfromhangzhouchina
AT duanxiuzhi gestationaldiabetesmellitusinthecovid19pandemicaretrospectivestudyfromhangzhouchina
AT zhubo gestationaldiabetesmellitusinthecovid19pandemicaretrospectivestudyfromhangzhouchina